BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14535873)

  • 1. Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance.
    Miehlke S; Schneider-Brachert W; Bästlein E; Ebert S; Kirsch C; Haferland C; Buchner M; Neumeyer M; Vieth M; Stolte M; Lehn N; Bayerdörffer E
    Aliment Pharmacol Ther; 2003 Oct; 18(8):799-804. PubMed ID: 14535873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection.
    Veldhuyzen Van Zanten S; Machado S; Lee J
    Aliment Pharmacol Ther; 2003 Jun; 17(11):1381-7. PubMed ID: 12786632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
    Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
    Tzivras M; Archimandritis A; Balatsos V; Delis V; Souyioultzis S; Skandalis N; Kanellopoulou E; Manika Z; Davaris P
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1185-9. PubMed ID: 9471024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease.
    Wongkusoltham P; Vilaichone RK; Kullavanijaya P; Phaosawadi K; Mahachai V
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S474-80. PubMed ID: 11529378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-week proton pump inhibitor-based triple therapy eradicates residual Helicobacter pylori after failed dual therapy.
    Sheu BS; Wu JJ; Yang HB; Huang AH; Lin XZ
    J Formos Med Assoc; 1998 Apr; 97(4):266-70. PubMed ID: 9585678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial.
    Gschwantler M; Dragosics B; Schütze K; Wurzer H; Hirschl AM; Pasching E; Wimmer M; Klimpfinger M; Oberhuber G; Brandstätter G; Hentschel E; Weiss W
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1063-9. PubMed ID: 10468682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease.
    Hurenkamp GJ; Van Der Ende A; Grundmeijer HG; Tytgat GN; Van Der Hulst RW
    Aliment Pharmacol Ther; 2000 Aug; 14(8):1065-70. PubMed ID: 10930901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains.
    Houben MH; Hensen EF; Rauws EA; Hulst RW; Hoff BW; Ende AV; Kate FJ; Tytgat GN
    Aliment Pharmacol Ther; 1999 Jul; 13(7):883-9. PubMed ID: 10383522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility testing before first-line treatment for
    Cosme A; Montes M; Ibarra B; Tamayo E; Alonso H; Mendarte U; Lizasoan J; Herreros-Villanueva M; Bujanda L
    World J Gastroenterol; 2017 May; 23(18):3367-3373. PubMed ID: 28566898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection?
    Goh KL; Parasakthi N; Chuah SY; Cheah PL; Lo YL; Chin SC
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1115-8. PubMed ID: 9663838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance.
    Wong BC; Wong WM; Wang WH; Fung FM; Lai KC; Chu KM; Yuen ST; Leung SY; Hu WH; Yuen MF; Lau GK; Chan CK; Lam SK
    Aliment Pharmacol Ther; 2001 Mar; 15(3):403-9. PubMed ID: 11207516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
    Kalach N; Benhamou PH; Bergeret M; Gottrand F; Husson MO; Barbier C; Dupont C; Raymond J
    Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esomeprazole-based 1-week triple therapy directed by susceptibility testing for eradication of Helicobacter pylori infection in children.
    Arenz T; Antos D; Rüssmann H; Alberer M; Buderus S; Kappler M; Koletzko S
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):180-4. PubMed ID: 16877981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study.
    Peitz U; Sulliga M; Wolle K; Leodolter A; Von Arnim U; Kahl S; Stolte M; Börsch G; Labenz J; Malfertheiner P
    Aliment Pharmacol Ther; 2002 Feb; 16(2):315-24. PubMed ID: 11860415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy).
    Yousfi MM; El-Zimaity HM; Cole RA; Genta RM; Graham DY
    Aliment Pharmacol Ther; 1996 Feb; 10(1):119-22. PubMed ID: 8871452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group.
    Fock KM; Chelvam P; Lim SG
    Aliment Pharmacol Ther; 2000 Feb; 14(2):225-31. PubMed ID: 10651664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
    Georgopoulos SD; Xirouchakis E; Martinez-Gonzalez B; Sgouras DN; Spiliadi C; Mentis AF; Laoudi F
    Helicobacter; 2013 Dec; 18(6):459-67. PubMed ID: 23714140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication.
    Choi IJ; Jung HC; Choi KW; Kim JH; Ahn DS; Yang US; Rew JS; Lee SI; Rhee JC; Chung IS; Chung JM; Hong WS
    Aliment Pharmacol Ther; 2002 Jan; 16(1):145-51. PubMed ID: 11856089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.